SeraNovo BV is pleased to announce the closing of a License Agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncology and neuroscience.
Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs, has acquired OcellO B.V., a privately owned contract research organization located in the Netherlands.
Stichting Proefdiervrij wants to increase and accelerate the impact of non-animal research on the use of laboratory animals and has therefore organised the first Animal-free Venture Challenge.
Study will examine the pharmacokinetics, safety and efficacy of sonlicromanol, one of the most advanced disease-modifying drug candidates in development for mitochondrial disease
Next to lung, liver or heart surgeries, MedicalVR technology can be implemented in a multidisciplinary setting of plastic & reconstructive, oncologic and cardiotho
The winners of the first Henri Termeer Transatlantic Connections Award have just been announced live in front of an online audience at the Innovation for Health event.